Fred Alger Management
PVLA icon

Fred Alger Management’s Palvella Therapeutics PVLA Stock Holding History

Fred Alger Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8M Buy
31,424
+10,188
+48% +$1.24M 0.02% 244
2026
Q1 		$2.65M Sell
21,236
-128,790
-86% -$13.4M 0.01% 290
2025
Q4 		$15.7M Sell
150,026
-36,725
-20% -$3.13M 0.06% 133
2025
Q3 		$11.7M Buy
186,751
+173,209
+1,279% +$7.72M 0.05% 170
2025
Q2 		$305K Buy
+13,542
New +$318K ﹤0.01% 400

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Fred Alger Management's PVLA Position: Q2 2026 in Review

Fred Alger Management increased its Palvella Therapeutics (PVLA) stake by 48% in Q2 2026, buying an estimated $1.24M and bringing the position to 31,424 shares worth $4.8M. The position accounts for 0.02% of the portfolio, ranked #244.

Fred Alger Management first reported a position in PVLA in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.7M in Q4 2025. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Fred Alger Management held 31,424 shares of Palvella Therapeutics worth $4.8M as of Q2 2026.
  • Fred Alger Management bought 10,188 Palvella Therapeutics shares in Q2 2026, an estimated $1.24M.
  • Palvella Therapeutics made up 0.02% of Fred Alger Management's portfolio in Q2 2026, its #244 holding.
  • Fred Alger Management first reported a position in Palvella Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Fred Alger Management's Palvella Therapeutics position peaked at $15.7M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.